Trial Profile
Safety and tolerability of Eribulin in metastatic breast cancer patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 09 Dec 2015 New trial record